When neurologists first studied the brains of people with Alzheimer’s, more than 100 years ago, they spotted two abnormal clumps of proteins — beta-amyloid…
As the vast majority of Alzheimer’s drugs fail in clinical trials, some researchers and companies are turning to non-invasive neurotechnology as an alternative approach…
There are different modalities of drugs, delivered in different formats, that work in different ways. One type of drug you may encounter often is…
From the crispy crunch of fresh veggies to the creamy indulgence of decadent desserts, we all have different food preferences. Our palates develop uniquely,…
The U.S. Environmental Protection Agency has announced a new standard for protecting the public from fine particulate air pollution, known as PM2.5 because the…